ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 136 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,113,272 | -44.3% | 8,684,232 | 0.0% | 3.06% | -38.0% |
| Q2 2023 | $82,760,731 | -13.4% | 8,684,232 | 0.0% | 4.94% | -28.5% |
| Q1 2023 | $95,526,552 | -25.7% | 8,684,232 | 0.0% | 6.92% | -13.5% |
| Q4 2022 | $128,526,634 | -22.6% | 8,684,232 | 0.0% | 7.99% | -37.5% |
| Q3 2022 | $165,956,000 | -7.7% | 8,684,232 | +3.0% | 12.78% | -24.7% |
| Q2 2022 | $179,733,000 | +10.6% | 8,434,232 | 0.0% | 16.96% | +22.5% |
| Q1 2022 | $162,443,000 | – | 8,434,232 | – | 13.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|